中国药品价格规制及其效果研究

发布时间：2018-02-22 23:29

本文关键词： 价格规制规制失灵政策建议　出处：《广东财经大学》2014年硕士论文　论文类型：学位论文

【摘要】：改革开放以来，我国经济得到了快速发展，人民生活也得到了大幅度的提高，但是经济的发展与民生问题出现冲突。人民的生活水平有了很大的提高，但是医患关系紧张，使得国民幸福指数降低，引起此现象的原因主要是中国药品费用持续上涨、药价虚高、药品市场秩序混乱等。医药行业的健康发展与国民生活密切相关，医药价格是否合理不仅关系到居民的身体健康与根本利益，而且影响到社会的和谐与稳定，是一项事关国计民生的大事。针对这些问题，政府也曾先后出台了一系列药品价格规制政策来规范药品市场。从建国初期的全面药品价格规制到改革开放初期的放松药品价格规制再到近年来逐步加强的药品价格规制措施，可以说药品价格规制经历了由紧到松，再由松到紧的历程，但都没有改善药品价格虚高与药价混乱的问题。本文试图从药品价格规制理论与中国药品价格规制实践两方面，通过定量和定性分析，找出我国药品价格规制中存在的问题，即药品价格规制失灵的根本原因，，从而对完善我国药品价格的规制提出合理的对策，为改善我国医药行业做出贡献。本文共分为六章，第一章主要介绍问题的研究背景、意义、研究技术路线和可能的创新之处，并收集、梳理了国内外的相关文献；第二部分主要介绍了有关价格规制的一些理论基础，并探究了药品市场的特殊性和对其进行规制的必要性；第三部分阐述了我国药品价格规制的发展历程和国外几种主要的价格规制模式，并对其进行简要评析；第四部分从定量和定性两方面对我国药品价格规制的政策效果进行评析；第五部分探究我国药品价格规制政策失灵的主要原因；第六部分，基于我国药品规制的现状与国外经验的借鉴，提出完善我国药品价格规制的对策建议。
[Abstract]:Since the reform and opening up, China's economy has developed rapidly, and the people's living standards have been greatly improved, but the economic development has come into conflict with people's livelihood problems. The people's living standards have been greatly improved, but the doctor-patient relationship is tense. The main causes of this phenomenon are the continuous rise in drug costs in China, the false high drug prices, the disorder in the pharmaceutical market, and so on. The healthy development of the pharmaceutical industry is closely related to the life of the people. Whether the price of medicine is reasonable or not is not only related to the health and fundamental interests of the residents, but also to the harmony and stability of the society. It is a matter of great concern to the national economy and the people's livelihood. In view of these problems, The government has also issued a series of drug price regulation policies successively to regulate the drug market. From the comprehensive drug price regulation in the early years of the founding of the people's Republic of China to the relaxation of the drug price regulation in the early stage of reform and opening up, to the drug price regulation measures that have been gradually strengthened in recent years. It can be said that drug price regulation has experienced the course from tight to loose, then from loose to tight, but none of them has improved the problem of false high drug price and chaotic drug price. This paper attempts to study the theory of drug price regulation and the practice of Chinese drug price regulation. Through quantitative and qualitative analysis, this paper finds out the problems existing in the regulation of drug price in China, that is, the root cause of the failure of drug price regulation, and puts forward reasonable countermeasures to perfect the regulation of drug price in China. To improve the pharmaceutical industry in China to make contributions. This paper is divided into six chapters. The first chapter mainly introduces the research background, significance, research technical route and possible innovations, and collects and combs the relevant literature at home and abroad. The second part mainly introduces some theoretical basis of price regulation, and probes into the particularity of drug market and the necessity of regulating it. The third part expounds the development course of drug price regulation in China and several main foreign price regulation modes, and makes a brief evaluation on it. Part 4th evaluates the policy effect of drug price regulation in China from quantitative and qualitative aspects. Part 5th explores the main reasons for the failure of the policy of drug price regulation in China, and part 6th, based on the current situation of drug regulation in China and the experience of foreign countries, puts forward some countermeasures and suggestions to perfect the regulation of drug price in China.
【学位授予单位】：广东财经大学
【学位级别】：硕士
【学位授予年份】：2014
【分类号】：F726;F426.72

【参考文献】